{"title": null, "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2015-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[Intradural extramedullary tumors. Retrospective cohort study assessing prognostic factors for functional outcome in adult patients / Tumores intradurales-extramedulares. Estudio retrospectivo de cohorte valorando factores predictores de \u00aboutcome\u00bb en pacientes adultos](https://pesquisa.bvsalud.org/portal/resource/en/ibc-224907) [Neurocirug\u00eda (Soc. Luso-Esp. Neurocir.)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Neurocirug\u00eda (Soc. Luso-Esp. Neurocir.)); 34(5): 256-267, sept. oct. 2023. ilus, tab\nABSTRACT\nObjective The purpose of this study is to analyze a series of patients with intradural extramedullary tumors (IDEM) and assess factors that may modify or determine the final long term outcome and management. Materials and methods Single Center, retrospective study of a series of surgical patients with IDEM lesions from our Institution operated between 2010 and 2021. Patients with less than 6 months of follow up were excluded. Several preoperative demographics, clinical, imaging and surgical features, as well as histopathology, recurrence and adjuvancy were assessed. Patients final clinical outcome was categorized using the McCormick scale. Results A total of 203 patients with a mean follow-up of 30.50 months (range 6130) were included. 57.64% of the analyzed population was female and the mean age was 50.51 years. The most frequent location of the tumors was dorsal (34.98%) followed by the lumbar region (32.02%). Total resection was achieved in 84.24% of cases, and the most frequent histopathology was Schwannoma (36.45%), followed by Meningioma (30.05%). Pain was the most usual initial symptom (63.05%). In our analysis, functional outcome after surgery was associated with statistical significance with preoperative McCormick grade, tumor type, EOR and postoperative complications such as hematoma and sphincter involvement. Conclusion The management of these lesions depends on many factors. It is worthy of mention that clinical presentation, EOR, histopathology and postoperative complications have shown significant prognostic value for the final outcome. Early treatment with the intention of achieving GTR when possible, using carefully tailored approaches, should be considered before the onset of significant symptoms (AU)\nObjetivo Analizar una serie de pacientes con tumores intradurales extramedulares y evaluar factores que pueden modificar o determinar el resultado final y el manejo a largo plazo. Materiales y m\u00e9todos Estudio monoc\u00e9ntrico, retrospectivo de una cohorte de pacientes quir\u00fargicos con lesiones intradurales extramedulares (IDEM) operados entre 2010 y 2021 y un m\u00ednimo de seis meses de seguimiento. Se evaluaron caracter\u00edsticas cl\u00ednicas, de imagen y quir\u00fargicas, histopatolog\u00eda, recurrencia y adyuvancia. El resultado cl\u00ednico final de los pacientes se categoriz\u00f3 utilizando la escala de McCormick. Resultados Se incluyeron un total de 203 pacientes con un seguimiento medio de 30,50 meses (rango 6-130). De la poblaci\u00f3n analizada, 57,64% era del sexo femenino y la edad media fue de 50,51 a\u00f1os. La localizaci\u00f3n m\u00e1s frecuente de los tumores fue dorsal (34,98%) seguida de la regi\u00f3n lumbar (32,02%). La resecci\u00f3n total se logr\u00f3 en 84,24% de los casos, y la histopatolog\u00eda m\u00e1s frecuente fue el schwannoma (36,45%), seguido del meningioma (30,05%). El dolor fue el s\u00edntoma inicial m\u00e1s habitual (63,05%). En nuestro an\u00e1lisis, el resultado funcional posoperatorio se asoci\u00f3 con significancia estad\u00edstica con el grado de McCormick preoperatorio, la histopatolog\u00eda, el grado de resecci\u00f3n y las complicaciones posoperatorias como el hematoma y la afectaci\u00f3n esfinteriana. Conclusi\u00f3n El manejo de estas lesiones depende de muchos factores. Cabe mencionar que la presentaci\u00f3n cl\u00ednica, el grado de resecci\u00f3n, la histopatolog\u00eda y las complicaciones posoperatorias han mostrado un importante valor pron\u00f3stico para el desenlace. Se debe considerar el tratamiento temprano con la intenci\u00f3n de lograr resecci\u00f3n total cuando sea posible, mediante abordajes cuidadosamente adaptados, antes de la aparici\u00f3n de s\u00edntomas significativos (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Male](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"), [Female](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"), [Middle Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"), [Spinal Cord Neoplasms/diagnostic imaging](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spinal Cord Neoplasms/diagnostic imaging\"), [Spinal Cord Neoplasms/surgery](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spinal Cord Neoplasms/surgery\"), [Retrospective Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Retrospective Studies\"), [Cohort Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cohort Studies\"), [Prognosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Prognosis\"), [Treatment Outcome](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Treatment Outcome\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\") [Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group](https://pesquisa.bvsalud.org/portal/resource/en/ibc-225082) [Clin. transl. oncol. (Print)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Clin. transl. oncol. (Print)); 25(10): 3021-3031, oct. 2023. ilus, tab, graf\nABSTRACT\nPurpose Both venous and arterial thrombotic events (VTE/AT) can be associated with immune checkpoint inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice. Methods/patients Retrospective, multicenter study promoted by the Thrombosis and Cancer Section of the Spanish Society of Medical Oncology (SEOM). Individuals with kidney or bladder cancer who initiated ICI between 01/01/2015 and 12/31/2020 were recruited. Minimum follow-up was 6 months (except in cases of demise). The primary objective was to calculate the incidence of ICI-associated VTE/AT and secondary objectives included to analyze their impact on survival and identify variables predictive of VTE/AT. Results 210 patients with kidney cancer were enrolled. The incidence of VTE/AT during follow-up (median 13 months) was 5.7%. Median overall survival (OS) was relatively lower among subjects with VTE/AT (16 months, 95% CI 0.0134.2 vs. 27 months, 95% CI 22.631.4; p = 0.43). Multivariate analysis failed to reveal predictive variables for developing VTE/ AT. 197 patients with bladder were enrolled. There was a 9.1% incidence rate of VTE/AT during follow-up (median 8 months). Median OS was somewhat higher in patients with VTE/AT (28 months, 95% CI 18.437.6 vs 25 months, 95% CI 20.729.3; p = 0.821). Serum albumin levels < 3.5 g/dl were predictive of VTE/ AT (p < 0.05). Conclusions There appears to be no association between developing VTE/AT and ICI use in patients with renal or bladder cancer. Serum albumin levels are a predictive factor in individuals with bladder cancer (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Male](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"), [Female](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"), [Adult](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"), [Middle Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"), [Carcinoma, Renal Cell/metabolism](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Renal Cell/metabolism\"), [Thrombosis/etiology](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Thrombosis/etiology\"), [Urinary Bladder Neoplasms/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Urinary Bladder Neoplasms/drug therapy\"), [Kidney Neoplasms/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Kidney Neoplasms/drug therapy\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Survival Analysis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Survival Analysis\"), [Retrospective Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Retrospective Studies\"), [Societies, Medical](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Societies, Medical\"), [Spain](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spain\") [Women's Views on Factors that Influence Utilisation of Postnatal Follow-Up in Oman: A descriptive, qualitative study.](https://pesquisa.bvsalud.org/portal/resource/en/mdl-37655088) [Sultan Qaboos Univ Med J](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Sultan Qaboos Univ Med J); 23(3): 360-369, 2023 Aug.\nABSTRACT\nObjectives: Postnatal follow-up care (PNFC) is critical for promoting maternal and newborn health and well-being. In Oman, women's utilisation of postnatal follow-up services has declined, with rates as low as 0.29 (mean visits) in some governorates, and fails to meet the recommendation of postnatal follow-up visits at two and six weeks for assessment of the mother and her newborn. The reasons for this low utilisation are not well understood. This study aimed to explore women's views on and identify factors that influence their utilisation of postnatal follow-up services. Methods: Purposive sampling was employed and semi-structured telephone interviews were conducted with 15 women aged 20-39 years at six to eight weeks post-childbirth between May and August 2021. The data were analysed using Erlingsson and Brysiewicz's content analysis approach. Results: The following six categories were identified as influencing PNFC utilisation: 1) need for information; 2) experiences and expectations; 3) family support, expectations and customs; 4) sociocultural beliefs and practice; 5) impact of the COVID-19 pandemic; and 6) the healthcare environment. Influencing factors derived from each category include the need to empower women, provide individualised care, address family and community expectations, offer alternatives to face-to-face clinic visits and provide organised and scheduled appointments. Conclusion: Women in Oman identified the need for consistent information from healthcare providers and a more organised postnatal follow-up service that includes scheduled appointments and a woman-centred approach to PNFC.\nSubject(s)\n[COVID-19](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"COVID-19\"), [Female](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"), [Infant, Newborn](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Infant, Newborn\"), [Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Oman](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Oman\"), [COVID-19/epidemiology](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"COVID-19/epidemiology\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Pandemics](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Pandemics\"), [Mothers](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Mothers\") [Pediatr Cardiol](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Pediatr Cardiol); 44(7): 1529-1535, 2023 Oct.\nABSTRACT\nLittle is known about the outcomes of children with second-degree heart block. We aimed to determine whether children with structurally normal hearts and Mobitz 1, 2:1 block or Mobitz 2 are at increased risk for progressing to complete heart block (CHB) or requiring a pacemaker (PM) at long-term follow-up. We searched our institutional electrophysiology database for children with potentially concerning second-degree block on ambulatory rhythm monitoring between 2009 and 2021, defined as frequent episodes of Mobitz 1 or 2:1 block, episodes of Mobitz 1 or 2:1 block with additional evidence of conduction disease (i.e. first-degree heart block, bundle branch block), or episodes of Mobitz 2. Ambulatory rhythm monitor, ECG, and demographic data were reviewed. The primary composite outcome was CHB on follow-up rhythm monitor or PM placement. 20 patients were in the final analysis. Six (30%) patients either developed CHB but do not have a PM (4 = 20%) or have a PM (2 = 10%). Median follow-up was 5.8 years (IQR 4.4-7.0). Patients with CHB or PM were more likely to have second-degree block at maximum sinus rate (67% vs. 0%, p = 0.003), a below normal average heart rate (67% vs. 14%, p = 0.04), and 2:1 block on initial ECG (50% vs. 0%, p = 0.02). In this study of children with potentially concerning second-degree block, 30% of patients progressed to CHB or required a PM. Second-degree block at maximum sinus rate, a low average heart, and 2:1 block on initial ECG were associated with increased risk of disease progression.\nSubject(s)\n[Atrioventricular Block](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Atrioventricular Block\"), [Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Child](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Child\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Cardiac Conduction System Disease](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiac Conduction System Disease\"), [Heart](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Heart\"), [Bundle-Branch Block/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Bundle-Branch Block/diagnosis\"), [Bundle-Branch Block/therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Bundle-Branch Block/therapy\") [Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study.](https://pesquisa.bvsalud.org/portal/resource/en/mdl-37658392) [Pediatr Rheumatol Online J](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Pediatr Rheumatol Online J); 21(1): 94, 2023 Sep 01.\nABSTRACT\nBACKGROUND: The aim of this long-term follow-up study was to compare the disease characteristics of HLA-B27 positive and negative patients with juvenile idiopathic arthritis (JIA). METHODS: The study is a cohort study with consecutive cases of newly diagnosed Finnish patients with JIA according to the International League of Associations for Rheumatology (ILAR) criteria [1]. Patients were enrolled between 1997 and 2000 from a defined area of Southern Finland. Clinical data including disease activity and serology were registered during a mean period of 17.5 years. RESULTS: 159 patients completed the 18-year follow-up study. HLA-B27 was available for 151 patients, of which 25% were HLA-B27 positive. Chronic uveitis was diagnosed in 30% of HLA-B27 positive and 29% of HLA-B27 negative patients. HLA-B27 positive patients had a lower prevalence of temporomandibular (TMJ) involvement than the antigen negative ones, 19% versus 28%. None of the HLA-B27 positive patients had cervical spine affected compared to 11% of antigen negative patients (p = 0.022). Of the HLA-B27 positive patients, 54% had had biological medication at some point during follow-up versus 25% in the negative group (p = 0.003). At last follow-up, 32% of antigen positive patients were not in remission compared to 18% of the antigen negative (p = 0.017). CONCLUSIONS: The use of biological medication was more common in HLA-B27 positive patients with JIA. At the 18-year follow-up, more antigen positive patients had active disease compared HLA-B27 negative patients. This real-world follow-up study indicates that the prospects for worse outcome with HLA-B27 positivity in long-term should be taken into consideration.\nSubject(s)\n[Arthritis, Juvenile](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Arthritis, Juvenile\"), [HLA-B27 Antigen](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"HLA-B27 Antigen\"), [Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Cohort Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cohort Studies\"), [Finland/epidemiology](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Finland/epidemiology\"), [HLA-B27 Antigen/genetics](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"HLA-B27 Antigen/genetics\"), [Arthritis, Juvenile/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Arthritis, Juvenile/drug therapy\"), [Arthritis, Juvenile/epidemiology](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Arthritis, Juvenile/epidemiology\") [Hemivertebra resection after age three produces the similar results but with less complications compared to earlier surgery: a minimum of 5-year follow-up.](https://pesquisa.bvsalud.org/portal/resource/en/mdl-37660023) [J Orthop Surg Res](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=J Orthop Surg Res); 18(1): 651, 2023 Sep 02.\nABSTRACT\nBACKGROUND: The optimal timing for hemivertebra resection remains controversial. Early intervention before 3 years of age seems being able to get better correction with less fusion segments. However, it was also reported that early surgery may be associated with more complications. The purpose of this study is to investigate correction outcomes and complications of delayed hemivertebra resection (between 3 and 5 years of age), in comparison with earlier surgery (before 3 years of age). METHODS: Patients who had undergone thoracolumbar hemivertebra resection at a single level before 5 years of age and had more than 5 years of follow-up were reviewed. Twenty-four patients had hemivertebra resection surgery below 3 years of age (early surgery, Group E), and 33 patients received surgery between 3 and 5 years of age (delayed surgery, Group D). Radiographs from preoperative, immediately postoperative, and the latest follow-up visits were reviewed to investigate the correction outcomes. Complications were recorded and compared between these two groups. RESULTS: The patients of Group E had shorter operation time and less blood loss than those of Group D (P = 0.003 and P = 0.006). Notably, the fusion segments were 2.3 \u00b1 0.7 and 3.1 \u00b1 1.2 in group E and group D (P = 0.005), respectively, indicating group E averagely saved 0.8 motion segments. At the time of surgery, group E had smaller main curve magnitude either in the coronal or in the sagittal plane than group D and experienced similar correction rates of scoliosis (83.3 \u00b1 21.6% vs. 81.2 \u00b1 20.1%, P = 0.707) and kyphosis (65.1 \u00b1 23.8% vs. 71.7 \u00b1 24.9%, P = 0.319). However, group E had relatively higher complication rates than group D and relatively greater correction loss in either coronal or sagittal plane during follow-up. CONCLUSIONS: Hemivertebra resection resulted in similar correction results in both age groups. However, the rate of complications was lower for Group D than Group E. Thus, for non-kyphotic hemivertebra, surgery may be delayed till 3 to 5 years of age.\nSubject(s)\n[Kyphosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Kyphosis\"), [Scoliosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Scoliosis\"), [Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Scoliosis/diagnostic imaging](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Scoliosis/diagnostic imaging\"), [Scoliosis/surgery](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Scoliosis/surgery\"), [Motion](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Motion\") [Evaluating the impact of continuing professional development courses on physician behavioral intention: a pre-post study with follow-up at six months.](https://pesquisa.bvsalud.org/portal/resource/en/mdl-37661265) [BMC Med Educ](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=BMC Med Educ); 23(1): 629, 2023 Sep 03.\nABSTRACT\nBACKGROUND: Continuing professional development (CPD) for health professionals includes educational activities to maintain or improve skills. We evaluated the impact of a series of CPD courses by identifying factors influencing physicians' intention to adopt targeted behaviors and assessing self-reported behavior adoption six months later. METHODS: In this pre-post study, eligible participants attended at least one in-person course at the F\u00e9d\u00e9ration des M\u00e9decins Sp\u00e9cialistes du Qu\u00e9bec annual meeting in November 2019. Before and afterwards, participants completed CPD-REACTION, a validated questionnaire based on Godin's integrated model for health professional behavior change that measures intention and psychosocial factors influencing intention. We used Wilcoxon signed-rank test to compare pre- and post-course intention scores and linear regression analyses to identify factors influencing intention. We also compared the post-course intention scores of participants reporting a behavior change six months later with the scores of those reporting no behavior change six months later. Qualitative data was collected only six months after courses and responses to open-ended questions were analyzed using the Theoretical Domains Framework. RESULTS: A total of 205/329 course attendees completed CPD-REACTION (response rate 62.3%). Among these participants, 158/329 (48%) completed the questionnaire before CPD courses, 129/329 (39.2%) only after courses and 47/329 (14.3%) at 6 months. Study population included 192 physicians of whom 78/192(40.6%) were female; 59/192(30.7%) were between 50 and 59 years old; and 72/192 (37.5%) were surgical specialist physicians. Mean intention scores before (n = 158) and after (n = 129) courses were 5.74(SD = 1.52) and 6.35(SD = 0.93) respectively. Differences in mean (DM) intention before and afterwards ranged from - 0.31(p = 0.17) to 2.25(p = 0.50). Multivariate analysis showed that beliefs about capabilities (\u00df = 0.15, p = 0.001), moral norm (\u00df = 0.75, p < 0.0001), and beliefs about consequences (\u00df = 0.11, p = 0.04) influenced post-course intention. Post-course intention was correlated with behavior six months later (DM = 0.63; p = 0.02). Qualitative analysis showed that facilitators to behavior adoption after six months were most often related to the TDF domains of beliefs about capabilities. Most frequent barriers to adoption related to lack of resources. CONCLUSIONS: Overall, scores for intention to adopt targeted behaviors increased after the courses. CPD providers could increase participants' intention by including interventions that emphasize beliefs about capabilities, moral norm and beliefs about consequences.\nSubject(s)\n[Physicians](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Physicians\"), [Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Female](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"), [Middle Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"), [Male](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Health Personnel](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Health Personnel\"), [Health Behavior](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Health Behavior\"), [Data Accuracy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Data Accuracy\") [Psychol Sport Exerc](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Psychol Sport Exerc); 66: 102375, 2023 May.\nABSTRACT\nA good set of cognitive and psycho-behavioural skills are beneficial for young athletes to overcome and benefit from developmental challenges. Unfortunately, there is still a dearth of knowledge on how both these cognitive (i.e., executive functions; EF) and psycho-behavioural (i.e., psychological characteristics of developing excellence; PCDE) skills develop in youth athletes. Especially for athletes in early specialisation sports such as artistic gymnastics, the early EF and PCDE development might be important to be able to cope with the pressure and challenges that comes with a transition to the next stage. In the current study, artistic gymnasts between 9 and 22 years old were tested twice with a 12-month interval to investigate the changes in EF and PCDE. Results showed that EF developed within the youngest stage, but plateaued at the later stages. Most PCDE did not seem to change over time within each stage. Furthermore, the transition to a new stage does not seem to coincide with an increased improvement of PCDE. However, with a case study approach in the oldest stages, still inter-individual differences in EF and PCDE scores over time were observed. This study shows that EF and PCDE develop over time, albeit in a non-linear way, and along a variety of developmental trajectories.\nSubject(s)\n[Athletes](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Athletes\"), [Gymnastics](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Gymnastics\"), [Adolescent](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adolescent\"), [Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Child](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Child\"), [Young Adult](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Young Adult\"), [Adult](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Cognition](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cognition\") [Transcutaneous Afferent Patterned Stimulation for Essential Tremor: Real-World Evidence with Long Term Follow-Up.](https://pesquisa.bvsalud.org/portal/resource/en/mdl-37663529) [Tremor Other Hyperkinet Mov (N Y)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Tremor Other Hyperkinet Mov (N Y)); 13: 29, 2023.\nABSTRACT\nBackground: Transcutaneous afferent patterned stimulation (TAPS) is a non-invasive neuromodulation therapy for the treatment of hand tremor in patients with essential tremor (ET). This retrospective post-market analysis evaluated the usage, effectiveness, and safety of TAPS in patients using TAPS beyond a 90-day trial period in a real-world setting. Methods: Study personnel screened a manufacturer's database for TAPS devices that had been prescribed for the treatment of ET and used beyond a 90-day trial period between August 2019 and January 2023. The device logs were collected to extract the therapy usage, accelerometry measurements, and on-board ratings of tremor improvement. Study personnel also evaluated results of a voluntary survey requested by the manufacturer after the 90-day trial period. Adverse events were assessed from patients' complaints reported to the manufacturer. Results: A total of 1,223 patients in the manufacturer's database met the study criteria. The patients had used therapy between 90 and 1,233 days, with average usage of 5.6 sessions per week. Accelerometry data indicated 89% of patients experienced tremor improvement, with an average 64% improvement. 63% of patients rated at least half of their sessions as improved. No significant habituation was observed in patients who used therapy for more than one year. Approximately 62% of survey respondents either had reduced medication or planned to consult physicians about their medication usage. No serious safety events were reported, and 10% of patients reported minor safety complaints. Discussion: The analysis demonstrates the real-world effectiveness and safety of TAPS beyond a 90-day trial period over a longer timeframe and in a larger population size than previously published evidence.\nSubject(s)\n[Essential Tremor](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Essential Tremor\"), [Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Essential Tremor/therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Essential Tremor/therapy\"), [Tremor](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Tremor\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Retrospective Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Retrospective Studies\"), [Accelerometry](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Accelerometry\") [Prognostic Evaluation of Microvolt T-Wave Alternans in Hypertrophic Cardiomyopathy: 9-year Clinical Follow-up. / Avalia\u00e7\u00e3o Progn\u00f3stica da Microaltern\u00e2ncia da onda T na Cardiomiopatia Hipertr\u00f3fica em um Seguimento Cl\u00ednico de 9 anos.](https://pesquisa.bvsalud.org/portal/resource/en/mdl-37672406) [Arq Bras Cardiol](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Arq Bras Cardiol); 120(8): e20220833, 2023.\nABSTRACT\nBACKGROUND: Sudden cardiac death (SCD) resulting from ventricular arrhythmia is the main complication of hypertrophic cardiomyopathy (HCM). Microvolt T-wave alternans (MTWA) is associated with the occurrence of ventricular arrhythmias in several heart diseases, but its role in HCM remains uncertain. OBJECTIVE: To evaluate the association of MTWA with the occurrence of SCD or potentially fatal ventricular arrhythmias in HCM patients in a long-term follow-up. METHODS: Patients diagnosed with HCM and NYHA functional class I-II were consecutively selected. At the beginning of the follow-up, the participants performed the MTWA evaluation using the modified moving average during the stress test. The results were classified as altered or normal. The composite endpoint of SCD, ventricular fibrillation, sustained ventricular tachycardia (SVT) or appropriate implantable cardiac defibrillation (ICD) therapy was assessed. The level of significance was set at 5%. RESULTS: A total of 132 patients (mean age of 39.5 \u00b1 12.6 years) were recruited and followed for a mean of 9.5 years. The MTWA test was altered in 74 (56%) participants and normal in 58 (44%). Nine events (6.8%) occurred during the follow-up, with a prevalence of 1.0%/year - six SCDs, two appropriate ICD shocks and one episode of (SVT). Altered MTWA was associated with non-sustained ventricular tachycardia on Holter (p = 0.016), septal thickness \u226530 mm (p < 0.001) and inadequate blood pressure response to effort (p = 0.046). Five patients with altered MTWA (7%) and four patients with normal MTWA (7%) had the primary outcome [OR = 0.85 (95% CI: 0.21 - 3.35, p=0.83)]. Kaplan-Meir event curves showed no differences between normal and altered MTWA. CONCLUSION: Altered MTWA was not associated with the occurrence of SCD or potentially fatal ventricular arrhythmias in HCM patients, and the low rate of these events during long-term follow-up suggests the good prognosis of this heart disease.\nFUNDAMENTO: A morte s\u00fabita card\u00edaca (MSC), decorrente de arritmias ventriculares, \u00e9 a principal complica\u00e7\u00e3o da cardiomiopatia hipertr\u00f3fica (CMH). A microaltern\u00e2ncia da onda T (MAOT) est\u00e1 associada \u00e0 ocorr\u00eancia de arritmias ventriculares em diversas cardiopatias, mas seu papel na CMH permanece incerto. OBJETIVO: Avaliar associa\u00e7\u00e3o da MAOT com a ocorr\u00eancia de MSC ou arritmias ventriculares malignas em pacientes com CMH. M\u00c9TODO: Pacientes com diagn\u00f3stico de CMH e classe funcional I-II (NYHA) foram selecionados de forma consecutiva. No in\u00edcio do seguimento os participantes realizaram a avalia\u00e7\u00e3o da MAOT pela metodologia da m\u00e9dia m\u00f3vel modificada no teste de esfor\u00e7o. Os resultados foram classificados em alterado ou normal. O desfecho foi composto por MSC, fibrila\u00e7\u00e3o ventricular, taquicardia ventricular sustentada (TVS) e terapia apropriada do cardioversor desfibrilador implant\u00e1vel (CDI). O n\u00edvel de signific\u00e2ncia estat\u00edstica foi de 5%. RESULTADOS: Um total de 132 pacientes (idade m\u00e9dia de 39,5\u00b112,6 anos) foram inclu\u00eddos, com tempo de seguimento m\u00e9dio de 9,5 anos. A MAOT foi alterada em 74 (56%) participantes e normal em 58 (44%). Durante o seguimento, nove (6,8%) desfechos ocorreram, com preval\u00eancia de 1,0%/ano, sendo seis casos de MSC, dois choques apropriados do CDI e um epis\u00f3dio de TVS. MAOT alterada foi associada \u00e0 taquicardia ventricular n\u00e3o sustentada no Holter (p=0,016), espessura septal\u226530 mm (p<0,001) e resposta inadequada da press\u00e3o arterial ao esfor\u00e7o (p=0,046). Cinco pacientes (7%) e quatro pacientes (7%) com MAOT alterada e normal, respectivamente, apresentaram desfecho prim\u00e1rio [OR=0,85(IC95%: 0,213,35, p=0,83)]. Curvas de eventos de Kaplan-Meir n\u00e3o apresentaram diferen\u00e7as entre MAOT normal e alterada. CONCLUS\u00c3O: A MAOT alterada n\u00e3o foi associada \u00e0 ocorr\u00eancia de MSC ou arritmias ventriculares potencialmente fatais em pacientes com CMH, e a baixa taxa desses eventos em um seguimento em longo prazo sugere o bom progn\u00f3stico dessa cardiopatia.\nSubject(s)\n[Cardiomyopathy, Hypertrophic](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiomyopathy, Hypertrophic\"), [Tachycardia, Ventricular](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Tachycardia, Ventricular\"), [Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Adult](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"), [Middle Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"), [Prognosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Prognosis\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Arrhythmias, Cardiac](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Arrhythmias, Cardiac\"), [Cardiomyopathy, Hypertrophic/complications](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiomyopathy, Hypertrophic/complications\"), [Cardiomyopathy, Hypertrophic/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiomyopathy, Hypertrophic/diagnosis\"), [Death, Sudden, Cardiac/etiology](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Death, Sudden, Cardiac/etiology\"), [Tachycardia, Ventricular/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Tachycardia, Ventricular/diagnosis\"), [Ventricular Fibrillation/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Ventricular Fibrillation/diagnosis\"), [Anti-Arrhythmia Agents](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Anti-Arrhythmia Agents\"), [Cardiotonic Agents](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiotonic Agents\"), [Diuretics](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Diuretics\") [Association between engagement in cultural activities and use of general practitioner consultations: 7-year follow-up of adults from the HUNT study, Norway.](https://pesquisa.bvsalud.org/portal/resource/en/mdl-37696637) [BMJ Open](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=BMJ Open); 13(9): e068004, 2023 09 11.\nABSTRACT\nOBJECTIVE: Assess whether engagement in a range of cultural activities, both 'passive' and 'active' (ie, receptive and creative) participation, is associated with later demand for general practitioner (GP) consultations. DESIGN: Longitudinal prospective cohort study. SETTING: Data from the population-based the third Survey of Tr\u00f8ndelag Health Study (2006-2008) in Norway was linked to an administrative register including service information from all GP offices nationwide. PARTICIPANTS: This study included 17 396 (54.6%) women and 14 451 (45.4%) men aged 30-79 years. MAIN OUTCOME MEASURES: Multilevel negative binomial regression models assessed the relationship between cultural engagement and GP consultations, and reported as rate ratios. RESULTS: A mean of 3.57 GP visits per patient was recorded during the 7 years of follow-up. Participation in creative activities and a combination of both receptive and creative activities was associated with lower number of GP consultation. Gender-specific analyses suggest that these effects were attributable to men. The rate ratio of GP consultations among men taking part in creative activities less than once, twice and more than twice (<9 times) per week is 0.90, 0.89 and 0.87 times lower, respectively, compared with non-participants. Whereas weekly frequency of receptive and creative activity engagement showed a 0.92, 0.87 and 0.83 times lower rate ratio among engaged men. The variety of activities shows a similar pattern and participation in creative activities lowers the rate ratio among men. Engagement in a wide range/variety of activities, compared with non-engagement, was associated with lower numbers of GP consultations in men, but not women. CONCLUSIONS: Engagement in creative or combined receptive and creative cultural activities was associated with lower numbers of GP consultations among men. Thus, facilitating and promoting a culturally engaged lifestyle, particularly in men, may affect primary healthcare use. However, this study design gives no evidence of a causal relationship between cultural engagement and use of GP consultations.\nSubject(s)\n[General Practitioners](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"General Practitioners\"), [Male](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"), [Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Adult](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"), [Female](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Prospective Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Prospective Studies\"), [Norway](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Norway\"), [Referral and Consultation](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Referral and Consultation\") [Feeling stressed and depressed? A three-wave follow-up study of the beneficial effects of voluntary work](https://pesquisa.bvsalud.org/portal/resource/en/ibc-218525) [Int. j. clin. health psychol. (Internet)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Int. j. clin. health psychol. (Internet)); 23(3)jul.-sep. 2023. ilus, graf, tab\nABSTRACT\nWhile symptoms of stress are a major risk factor in the onset of depressive symptoms and major depression, a better understanding of intervening mechanisms in breaking down this positive association is urgently required. It is within this literature that we investigate (1) how symptoms of stress are associated with depressive symptoms and the onset of major depression, and (2) the buffering effect of hours spent on voluntary work on the stress-depression relationship. Using 3-wave longitudinal data, we estimated a direct and reverse auto-regressive path model. We found both cross-sectional and longitudinal support for the positive association between symptoms of stress and depressive symptoms. Next, we found that individuals who experienced more symptoms of stress at T1, T2, and T3 were 1.64 (95%CI [1.46;1.91]), 1.49 (95%CI [1.24;1.74]), and 1.40 (95%CI [1.21;1.60]) times more likely to be prescribed an anti-depression treatment at T3, respectively. Moreover, we found that the number of hours spent volunteering mitigated the (1) longitudinalbut not cross-sectionalstress-depression relationship, and (2) cross-sectionalbut not the longitudinalassociation between symptoms of stress at T3 and the likelihood of being prescribed an anti-depression treatment. These results point toward the pivotal role of voluntary work in reducing the development of depressive symptoms and major depression in relation to the experience of symptoms of stress. (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Stress, Psychological](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Stress, Psychological\"), [Depression](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Depression\"), [Mental Health](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Mental Health\"), [Volunteers](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Volunteers\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Antidepressive Agents](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Antidepressive Agents\") [L\u00edneas de mejora asistencial entre dermat\u00f3logos y farmac\u00e9uticos hospitalarios para el manejo y seguimiento de la dermatitis at\u00f3pica: consenso Delphi / Improving the Management and Follow-up of Atopic Dermatitis: A Delphi Process Report of Consensus Between Hospital Dermatologists and Pharmacists](https://pesquisa.bvsalud.org/portal/resource/en/ibc-ADZ-379) [Actas dermo-sifiliogr. (Ed. impr.)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Actas dermo-sifiliogr. (Ed. impr.)); 114(8): 708-717, sept. 2023.\nABSTRACT\nEl control de la dermatitis at\u00f3pica (DA), una de las dermatosis m\u00e1s frecuentes, es en muchas ocasiones un reto terap\u00e9utico. En el presente estudio se ha utilizado la metodolog\u00eda Delphi con el objetivo de poner en com\u00fan las perspectivas del dermat\u00f3logo y del farmac\u00e9utico hospitalario ante el manejo de la DA y establecer una serie de recomendaciones de actuaci\u00f3n adaptadas a las diferentes situaciones que plantea la enfermedad. El cuestionario Delphi ha sido definido por un comit\u00e9 cient\u00edfico y se ha dividido en 2bloques: 1) valoraci\u00f3n de la respuesta al tratamiento del paciente con DA, y 2) cooperaci\u00f3n entre Dermatolog\u00eda y Farmacia Hospitalaria (FH). Como resultado del estudio, se ha alcanzado un consenso total del 86%. Se concluye que el dermat\u00f3logo y el farmac\u00e9utico hospitalario deben tener una buena comunicaci\u00f3n y trabajar coordinados para conseguir optimizar el manejo del paciente con DA y su respuesta al tratamiento (AU)\nManaging atopic dermatitis, one of the most common dermatologic conditions, is often challenging. To establish consensus on recommendations for responding to various situations that arise when treating atopic dermatitis, a group of hospital pharmacists and dermatologists used the Delphi process. A scientific committee developed a Delphi survey with 2 blocks of questions to explore the group's views on 1) evaluating response to treatment in the patient with atopic dermatitis and 2) cooperation between the dermatology department and the hospital pharmacy service. The experts achieved an overall rate of consensus of 86% during the process. Conclusions were that dermatologists and hospital pharmacists must maintain good communication and coordinate their interventions to optimize the management of atopic dermatitis and patients responses to treatment (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Pharmacy Service, Hospital](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Pharmacy Service, Hospital\"), [Dermatitis, Atopic/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Dermatitis, Atopic/drug therapy\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Delphi Technique](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Delphi Technique\"), [Consensus](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Consensus\") [[Translated article] Improving the Management and Follow-up of Atopic Dermatitis: A Delphi Process Report of Consensus Between Hospital Dermatologists and Pharmacists / L\u00edneas de mejora asistencial entre dermat\u00f3logos y farmac\u00e9uticos hospitalarios para el manejo y seguimiento de la dermatitis at\u00f3pica: consenso Delphi](https://pesquisa.bvsalud.org/portal/resource/en/ibc-ADZ-380) [Actas dermo-sifiliogr. (Ed. impr.)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Actas dermo-sifiliogr. (Ed. impr.)); 114(8): t708-t717, sept. 2023. tab\nABSTRACT\nManaging atopic dermatitis, one of the most common dermatologic conditions, is often challenging. To establish consensus on recommendations for responding to various situations that arise when treating atopic dermatitis, a group of hospital pharmacists and dermatologists used the Delphi process. A scientific committee developed a Delphi survey with 2 blocks of questions to explore the group's views on 1) evaluating response to treatment in the patient with atopic dermatitis and 2) cooperation between the dermatology department and the hospital pharmacy service. The experts achieved an overall rate of consensus of 86% during the process. Conclusions were that dermatologists and hospital pharmacists must maintain good communication and coordinate their interventions to optimize the management of atopic dermatitis and patients responses to treatment (AU)\nEl control de la dermatitis at\u00f3pica (DA), una de las dermatosis m\u00e1s frecuentes, es en muchas ocasiones un reto terap\u00e9utico. En el presente estudio se ha utilizado la metodolog\u00eda Delphi con el objetivo de poner en com\u00fan las perspectivas del dermat\u00f3logo y del farmac\u00e9utico hospitalario ante el manejo de la DA y establecer una serie de recomendaciones de actuaci\u00f3n adaptadas a las diferentes situaciones que plantea la enfermedad. El cuestionario Delphi ha sido definido por un comit\u00e9 cient\u00edfico y se ha dividido en 2bloques: 1) valoraci\u00f3n de la respuesta al tratamiento del paciente con DA, y 2) cooperaci\u00f3n entre Dermatolog\u00eda y Farmacia Hospitalaria (FH). Como resultado del estudio, se ha alcanzado un consenso total del 86%. Se concluye que el dermat\u00f3logo y el farmac\u00e9utico hospitalario deben tener una buena comunicaci\u00f3n y trabajar coordinados para conseguir optimizar el manejo del paciente con DA y su respuesta al tratamiento (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Pharmacy Service, Hospital](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Pharmacy Service, Hospital\"), [Dermatitis, Atopic/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Dermatitis, Atopic/drug therapy\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Delphi Technique](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Delphi Technique\"), [Consensus](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Consensus\") [Trombosis venosa cerebral en adultos: cohorte de 35 casos de un hospital terciario / Cerebral venous thrombosis in adults: A case series of 35 patients from a tertiary hospital](https://pesquisa.bvsalud.org/portal/resource/en/ibc-223438) [Rev. cl\u00edn. esp. (Ed. impr.)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Rev. cl\u00edn. esp. (Ed. impr.)); 223(7): 423-432, ago.- sept. 2023. ilus, tab\nABSTRACT\nObjetivos Describir las caracter\u00edsticas basales, de presentaci\u00f3n cl\u00ednica, de imagen y evoluci\u00f3n e identificar potenciales factores pron\u00f3sticos en una cohorte de pacientes con trombosis venosa cerebral (TVC). Pacientes y m\u00e9todos Estudio observacional retrospectivo, unic\u00e9ntrico, que incluye a pacientes adultos con diagn\u00f3stico de TVC desde enero 2016 hasta diciembre 2020. Las variables fueron recogidas a trav\u00e9s de la historia cl\u00ednica electr\u00f3nica. Resultados Se incluyeron 35 pacientes con una edad media al diagn\u00f3stico de 50,3 (\u00b117,8) a\u00f1os, siendo la mayor\u00eda mujeres (74,4%). El 95% de los pacientes presentaba al menos un factor de riesgo para el desarrollo de TVC. El 97,1% recibi\u00f3 tratamiento anticoagulante con heparinas en la fase aguda, en su mayor\u00eda heparina de bajo peso molecular (75%). El evento compuesto (muerte, ingreso en unidad de cuidados intensivos, National institute of Health Stroke Scale al alta >3, recurrencia de TVC, hemorragia mayor, o la presencia de complicaciones) en las primeras dos semanas ocurri\u00f3 en el 28,6%. El seguimiento medio fue de 3,3 a\u00f1os, durante el cual el 14,3% falleci\u00f3 (solo un paciente en relaci\u00f3n con la TVC), un paciente present\u00f3 hemorragia mayor y ning\u00fan paciente present\u00f3 recurrencia de TVC. Conclusiones En nuestra cohorte, la TVC afect\u00f3 con mayor frecuencia a mujeres j\u00f3venes, y ocurri\u00f3 en pacientes con al menos un factor de riesgo para TVC. La presencia de edema en la tomograf\u00eda computarizada y el tratamiento con corticosteroides asociaron un peor pron\u00f3stico a corto plazo. Se observ\u00f3 un buen pron\u00f3stico a largo plazo en t\u00e9rminos de mortalidad, recurrencia y sangrado (AU)\nObjective To describe the baseline characteristics, clinical presentation, imaging tests and outcomes, and identify potential prognostic factors in a cohort of patients diagnosed with cerebral venous thrombosis (CVT). Patients and methods This retrospective, single-center, observational study included adult patients diagnosed with CVT from January 2016 to December 2020. The variables were reviewed using electronic medical records. Results A total of 35 patients were included, with a median age at diagnosis of 50.3 (\u00b1 17.8) years, and the majority being women (74.4%). Nearly 95% of the patients presented at least one risk factor for the development of CVT. Heparins were used for the acute phase in 97.1% of cases, with 75% of those being low molecular weight heparins. During the first two weeks, a compound event (death, intensive care unit admission, National Institute of Health Stroke Scale at discharge >3, CVT recurrence, major bleeding, or the presence of complications) occurred in 28.6% of patients (10 patients). Over the mean follow-up period of 3.3 years, 14.3% of the patients died (with only one death attributed to CVT), one patient experienced major bleeding, and no patients had a recurrence of CVT. Conclusions In our cohort, CVT predominantly affected young women with at least one risk factor for its development. The presence of edema on CT and corticosteroid treatment were associated with a poor short-term prognosis. However, we observed a favorable long-term prognosis in terms of mortality, recurrence, and bleeding (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Male](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"), [Female](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"), [Adolescent](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adolescent\"), [Young Adult](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Young Adult\"), [Adult](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"), [Middle Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"), [Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged\"), [Intracranial Thrombosis/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Intracranial Thrombosis/diagnosis\"), [Venous Thrombosis/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Venous Thrombosis/diagnosis\"), [Retrospective Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Retrospective Studies\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Recurrence](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Recurrence\"), [Venous Thrombosis/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Venous Thrombosis/drug therapy\"), [Venous Thrombosis/etiology](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Venous Thrombosis/etiology\"), [Intracranial Thrombosis/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Intracranial Thrombosis/drug therapy\"), [Intracranial Thrombosis/etiology](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Intracranial Thrombosis/etiology\"), [Risk Factors](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Risk Factors\"), [Prognosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Prognosis\") [SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)](https://pesquisa.bvsalud.org/portal/resource/en/ibc-224133) [Clin. transl. oncol. (Print)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Clin. transl. oncol. (Print)); 25(9): 2679-2691, sept. 2023. ilus, tab\nABSTRACT\nSEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Antineoplastic Combined Chemotherapy Protocols/administration & dosage](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Antineoplastic Combined Chemotherapy Protocols/administration %26 dosage\"), [Etoposide/therapeutic use](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Etoposide/therapeutic use\"), [Lung Neoplasms/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lung Neoplasms/diagnosis\"), [Lung Neoplasms/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lung Neoplasms/drug therapy\"), [Platinum/therapeutic use](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Platinum/therapeutic use\"), [Carcinoma, Non-Small-Cell Lung/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Non-Small-Cell Lung/diagnosis\"), [Carcinoma, Non-Small-Cell Lung/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Non-Small-Cell Lung/drug therapy\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Societies, Medical](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Societies, Medical\"), [Spain](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spain\") [Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)](https://pesquisa.bvsalud.org/portal/resource/en/ibc-224140) [Clin. transl. oncol. (Print)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Clin. transl. oncol. (Print)); 25(9): 2760-2762, sept. 2023. tab\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Antineoplastic Combined Chemotherapy Protocols/administration & dosage](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Antineoplastic Combined Chemotherapy Protocols/administration %26 dosage\"), [Etoposide/therapeutic use](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Etoposide/therapeutic use\"), [Lung Neoplasms/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lung Neoplasms/diagnosis\"), [Lung Neoplasms/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lung Neoplasms/drug therapy\"), [Platinum/therapeutic use](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Platinum/therapeutic use\"), [Carcinoma, Non-Small-Cell Lung/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Non-Small-Cell Lung/diagnosis\"), [Carcinoma, Non-Small-Cell Lung/drug therapy](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Non-Small-Cell Lung/drug therapy\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Societies, Medical](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Societies, Medical\"), [Spain](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spain\") [Experiencia de 20 a\u00f1os en el control de la hipertensi\u00f3n arterial en un centro de salud en Espa\u00f1a: control estricto versus no estricto / Twenty-year experience in strict versus non-strict control of arterial hypertension in a health center in Spain](https://pesquisa.bvsalud.org/portal/resource/en/ibc-224800) [SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.)); 49(6): [e101999], sept. 2023. tab, graf\nABSTRACT\nIntroducci\u00f3n y objetivos En los ensayos cl\u00ednicos la reducci\u00f3n eficaz de la presi\u00f3n arterial (PA) produce una disminuci\u00f3n de la incidencia de la morbimortalidad cardiovascular (CV). Nuestro objetivo principal es conocer si en las condiciones reales de la pr\u00e1ctica cl\u00ednica el control de la PA reduce a largo plazo los eventos CV. Pacientes y m\u00e9todos El estudio se realiz\u00f3 en 164 pacientes con hipertensi\u00f3n arterial (HTA) elegidos entre los pacientes que acud\u00edan a las consultas de medicina de familia por HTA. Se hizo un an\u00e1lisis entre los pacientes que presentaban una PA cl\u00ednica inferior a 140/90mmHg y los que la ten\u00edan m\u00e1s elevada. Los pacientes se segu\u00edan hasta que se produc\u00eda un evento CV o hasta un m\u00e1ximo de 20 a\u00f1os, en que se finalizaba el seguimiento. Resultados Del total de los 164 pacientes alcanzaron un buen control cl\u00ednico de la HTA 93 (56,7%) pacientes y no lo alcanzaron 71 (42,2%). En el an\u00e1lisis multivariante qued\u00f3 \u00fanicamente como variable predictora de eventos CV la falta de control estricto de la HTA (HR: 2,93; IC 95%: 1,45-5,89; p=0,003), y el sexo femenino fue protector para eventos CV (HR: 0,37; IC 95%: 0,18-0,74; p=0,005) Conclusiones La variable predictora fundamental de morbimortalidad CV en pacientes con HTA es la falta de control estricto de la HTA; las mujeres tambi\u00e9n tuvieron menos complicaciones CV (AU)\nIntroduction and aims During clinical trials effective reduction of blood pressure (BP) leads to a reduction in the incidence of cardiovascular (CV) morbimortality. Our main aim is to ascertain whether, under actual conditions of clinical practice, BP monitoring leads to a long-term reduction in CV events. Patients and methods The study was performed on 164 patients with hypertension (HT) selected among patients who came to family medicine consultations because of HT. An analysis was performed between patients who presented clinical BP lower than 140/90mmHg and those that had higher levels. When patients entered the study, they were followed up until a CV event occurred or up to a maximum of 20 years, at which time follow up ended. Results Of the total of 164 patients, good control of BP was attained by 93 (56.7%), and 71 did not attain good control (42.2%). In the multivariate analysis, the only predictive variable for CV events was the lack of strict control of BP (HR: 2.93; 95% CI: 1.45-5.89; p=0.003), and the female sex was protective for CV events (HR: 0.37; 95% CI: 0.18-0.74; p=0.005). Conclusions The fundamental predictor variable of CV morbimortality in patients with HT is the lack of HT strict control; the women also had fewer CV complications (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Male](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"), [Female](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"), [Middle Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"), [Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged\"), [Primary Prevention](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Primary Prevention\"), [Hypertension/prevention & control](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Hypertension/prevention %26 control\"), [Risk Factors](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Risk Factors\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"), [Spain](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spain\") [Facoemulsificaci\u00f3n y trabeculostom\u00eda con l\u00e1ser exc\u00edmero en ojos con hipertensi\u00f3n ocular o glaucoma leve y catarata. Experiencia real, eficacia y seguridad / Real life experience following combined excimer laser trabeculostomy and phacoemulsification in eyes with ocular hypertension or mild glaucoma and cataract](https://pesquisa.bvsalud.org/portal/resource/en/ibc-224813) [Arch. Soc. Esp. Oftalmol](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Arch. Soc. Esp. Oftalmol); 98(9): 521-527, sept. 2023. tab, graf\nABSTRACT\nObjetivo Evaluar la eficacia y la seguridad de la trabeculostom\u00eda con l\u00e1ser exc\u00edmero (ELT) y facoemulsificaci\u00f3n en ojos con hipertensi\u00f3n ocular (HTO) o glaucoma leve y catarata. M\u00e9todos Estudio unic\u00e9ntrico de ojos a los que se realiz\u00f3 facoemulsificaci\u00f3n y ELT entre 2017 y 2021. Se evalu\u00f3 el cambio en la presi\u00f3n intraocular (PIO), la necesidad de medicamentos para controlar la PIO, la agudeza visual mejor corregida, las complicaciones y las reintervenciones. El \u00e9xito del procedimiento se defini\u00f3 como una reducci\u00f3n del 20% de la PIO, una PIO \u226414mmHg o la reducci\u00f3n de medicamentos con una PIO menor o igual a la preoperatoria. Resultados El seguimiento promedio fue de 658 \u00b164d\u00edas. El promedio de PIO preoperatoria fue 17,76 \u00b14,88mmHg y disminuy\u00f3 a 15,35 \u00b13,10mmHg al a\u00f1o de seguimiento (n=37) (p = 0,006) y a 14,00 \u00b13,78mmHg a los 3a\u00f1os (n=8) (p=0,074). El n\u00famero de medicamentos para controlar la PIO disminuy\u00f3 de 2,02 \u00b11,00 en el preoperatorio a 1,02 \u00b10,96 al a\u00f1o (n=37) (p<0,001) y a 1,63 \u00b10,92 a los 3a\u00f1os de seguimiento (n=8) (p=0,197). El \u00e9xito completo se alcanz\u00f3 en el 17,7% de los ojos y el \u00e9xito calificado en el 54,8%. Dos ojos de 2 pacientes presentaron hipema postoperatorio temprano. Dos ojos de un paciente requirieron una cirug\u00eda filtrante y dos ojos de un paciente una trabeculoplastia selectiva para controlar la PIO. Conclusiones La combinaci\u00f3n de ELT y facoemulsificaci\u00f3n es efectiva y segura en ojos con HTO o glaucoma leve y catarata. En esta serie hubo una reducci\u00f3n significativa de la PIO y del n\u00famero de medicamentos para controlar la PIO (AU)\nObjective To assess the efficacy and safety of combined phacoemulsification and excimer laser trabeculostomy (ELT) in eyes with cataract and mild controlled glaucoma or ocular hypertension (OHT). Methods Single-centre analysis of eyes that underwent phacoemulsification and ELT between 2017 and 2021. Change in intraocular pressure (IOP), glaucoma medication requirements, corrected distance visual acuity (CDVA), complications and re-interventions were evaluated. Success was defined as a reduction \u226520% from preoperative IOP, an IOP \u226414mmHg or a reduction in glaucoma medication requirements with an IOP equal or lower than the preoperative IOP. Results Mean follow-up was 658 \u00b164days. Mean preoperative IOP was 17.76 \u00b14.88mmHg, it decreased to 15.35 \u00b13.10mmHg at 1 year (n=37) (P=.006) and to 14.00 \u00b13.78 at 3years (n=8) (P=.074). Mean number of glaucoma medication requirements decreased from 2.02 \u00b11.0 preoperatively to 1.02 \u00b10.96 at 1 year (n=37) (P<.001) and to 1.63 \u00b10.92 at 3years (n=8) (P=.197). Complete success was achieved in 17.7% of eyes and qualified success in 54.8%. Two eyes of 2 patients had early postoperative hyphema. Two eyes of 1 patient underwent filtering surgery 2 months after the procedure, and 2 eyes of 1 patient underwent laser trabeculoplasty 3.8years after the procedure due to uncontrolled IOP. Conclusions Combined phacoemulsification and ELT is effective and safe in eyes with mild glaucoma or OHT and cataract. It significantly reduced IOP and glaucoma medication requirements 1 year after surgery (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Male](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"), [Female](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"), [Middle Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"), [Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged\"), [Aged, 80 and over](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged, 80 and over\"), [Cataract Extraction](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cataract Extraction\"), [Glaucoma/surgery](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Glaucoma/surgery\"), [Lasers, Excimer](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lasers, Excimer\"), [Ocular Hypertension/surgery](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Ocular Hypertension/surgery\"), [Phacoemulsification](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Phacoemulsification\"), [Severity of Illness Index](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Severity of Illness Index\"), [Treatment Outcome](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Treatment Outcome\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\") [Resecci\u00f3n tarsal vertical limitada en un caso de carcinoma basocelular de p\u00e1rpado inferior / Limited vertical tarsal resection in a case of basal cell carcinoma of the lower eyelid](https://pesquisa.bvsalud.org/portal/resource/en/ibc-224816) [Arch. Soc. Esp. Oftalmol](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Arch. Soc. Esp. Oftalmol); 98(9): 540-543, sept. 2023. ilus\nABSTRACT\nExponemos el caso cl\u00ednico de una mujer de 71 a\u00f1os de edad con antecedente de m\u00faltiples carcinomas basocelulares (CBC) que presenta una lesi\u00f3n nodular en la totalidad de la extensi\u00f3n del borde libre de p\u00e1rpado inferior. Se realiza un abordaje de la lesi\u00f3n mediante ex\u00e9resis del margen palpebral con resecci\u00f3n limitada vertical de tarso y colgajo de Tripier con un resultado est\u00e9tico y funcional correcto, m\u00e1rgenes histol\u00f3gicos libres y ausencia de recidiva en un seguimiento de 12 meses (AU)\nWe present the clinical case of a 71-year-old woman with a history of multiple basal cell carcinomas (BCC) who presented a nodular lesion in practically the entire extension of the free edge of the lower eyelid. The lesion was approached by excision of the palpebral margin with limited vertical resection of the tarsus and Tripier flap with a correct aesthetic and functional result, free histological margins and no recurrence in a 12-month follow-up (AU)\nSubject(s)\n[Humans](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"), [Female](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"), [Aged](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged\"), [Carcinoma, Basal Cell/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Basal Cell/diagnosis\"), [Carcinoma, Basal Cell/surgery](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Basal Cell/surgery\"), [Eyelid Neoplasms/diagnosis](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Eyelid Neoplasms/diagnosis\"), [Eyelid Neoplasms/surgery](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Eyelid Neoplasms/surgery\"), [Treatment Outcome](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Treatment Outcome\"), [Follow-Up Studies](https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\")", "language": null, "image": null, "pagetype": null, "links": ["#main_container", "#pesquisa", "#footer", "#", "#", "#", "#", "https://politicas.bireme.org/accesibilidad/en/", "http://bvsalud.org/en/", "javascript:change_language('pt')", "javascript:change_language('es')", "javascript:change_language('en')", "javascript:change_language('fr')", "javascript:decs_locator('https://pesquisa.bvsalud.org/portal/')", "https://pesquisa.bvsalud.org/portal/advanced/?lang=en", "http://bvsalud.org/evideasy/en", "#", "http://bvsalud.org/en/", "https://pesquisa.bvsalud.org/portal/?lang=en", "javascript: change_count('50');", "javascript: change_count('100');", "javascript: add_filter('fulltext_1');", "javascript: add_filter('db_9694536e389027f4efcec8439a41b9b2');", "javascript: add_filter('db_b3e53a2f66accb5cc5e625f85ab0032f');", "javascript: add_filter('db_22ceb9460f1875ce7ae51815a1ad949b');", "javascript: add_filter('db_7df605d05f12cabd92d5ceb30a8a29bb');", "javascript: add_filter('db_b65a90ade623bd4d42d64cc66c3ad85a');", "javascript: add_filter('db_ba03a2b9165631c8e881a0f4c41019ff');", "javascript: add_filter('db_55e5284cca4965cbc91a013339d919e8');", "javascript: add_filter('db_ce633e586c76c366aebbf3d7226f5fba');", "javascript: add_filter('db_2a723053ab15920e0c2ecd25a2ede6f9');", null, "javascript:show_more_clusters('db', 20);", "javascript: add_filter('mj_cluster_11d920e27759bbc7177aef8e5e940717');", "javascript: add_filter('mj_cluster_12681ecea9c659e8d64dd2eb4d66e117');", "javascript: add_filter('mj_cluster_fd46a662c92164802f60e654a768351f');", "javascript: add_filter('mj_cluster_b13a941497ed68c63b6ead1ec1649809');", "javascript: add_filter('mj_cluster_700488911516eb6fec4eeff368ba9206');", "javascript: add_filter('mj_cluster_950c8a2ec9861ed31c8f4c95fc7d3467');", "javascript: add_filter('mj_cluster_ea5fef550a910a2c60d30916913b5c31');", "javascript: add_filter('mj_cluster_18e9d0321b0f8e989665e3081090eb80');", "javascript: add_filter('mj_cluster_d4c66a654b5be56235c9510d8a05fe76');", "javascript: add_filter('mj_cluster_fe45789129e208dfe1dbe246515800e1');", null, "javascript:show_more_clusters('mj_cluster', 20);", "javascript: add_filter('type_of_study_ba336ad893756fe6dcd519f1f68c51da');", "javascript: add_filter('type_of_study_b0804d7579bf54d1ecba400718e0dfb1');", "javascript: add_filter('type_of_study_4c219e5f1697a14b0a9c5bdf69df5bb8');", "javascript: add_filter('type_of_study_bbbac17b8d3cb65abc2fc7fad7b6106e');", "javascript: add_filter('type_of_study_a2c398063346b019347556f5a3dc63f9');", "javascript: add_filter('type_of_study_834d93a9855c0da101e15b5214790ac7');", "javascript: add_filter('type_of_study_73667e92c67c55745489112658d55dfb');", "javascript: add_filter('type_of_study_8ab8b3bd23ff491dcc48d24d0366f71a');", "javascript: add_filter('type_of_study_4918d3b37d4424ac637a0f74feca643c');", "javascript: add_filter('type_of_study_eac6a3d30e3aa15afdc0c245156172af');", null, "javascript:show_more_clusters('type_of_study', 20);", "javascript: add_filter('la_9cfefed8fb9497baa5cd519d7d2bb5d7');", "javascript: add_filter('la_5f02f0889301fd7be1ac972c11bf3e7d');", "javascript: add_filter('la_ed73f6b46391b95e1d03c6818a73b8b9');", "javascript: add_filter('la_82a9e4d26595c87ab6e442391d8c5bba');", "javascript: add_filter('la_0f4dbe309348718e246f4566bbb76602');", "javascript: add_filter('la_89484b14b36a8d5329426a3d944d2983');", "javascript: add_filter('la_12470fe406d44017d96eab37dd65fc14');", "javascript: add_filter('la_0d149b90e7394297301c90191ae775f0');", "javascript: add_filter('la_288404204e3d452229308317344a285d');", "javascript: add_filter('la_a78c5bf69b40d464b954ef76815c6fa0');", null, "javascript:show_more_clusters('la', 20);", "#", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-224907", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Ruella, Mauro\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Caffaratti, Guido\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Saenz, Amparo\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Villamil, Facundo\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Mormandi, Rub\u00e9n\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Cervio, Andr\u00e9s\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Neurocirug\u00eda (Soc. Luso-Esp. Neurocir.)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spinal Cord Neoplasms/diagnostic imaging\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spinal Cord Neoplasms/surgery\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Retrospective Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cohort Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Prognosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Treatment Outcome\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-225082", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"S\u00e1nchez C\u00e1novas, Manuel\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Fern\u00e1ndez Garay, David\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Guirao Garc\u00eda, Esperanza\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"L\u00f3pez Robles, Javier\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Cacho Lavin, Diego\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Mart\u00ednez de Castro, Eva\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Campos Balea, Bego\u00f1a\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Garrido Fern\u00e1ndez, Alberto\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Fern\u00e1ndez P\u00e9rez, Isaura\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Ferr\u00e1ndez Arias, Asia\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Clin. transl. oncol. (Print)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Renal Cell/metabolism\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Thrombosis/etiology\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Urinary Bladder Neoplasms/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Kidney Neoplasms/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Survival Analysis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Retrospective Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Societies, Medical\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spain\"", "https://pesquisa.bvsalud.org/portal/resource/en/mdl-37655088", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Al Hadi, Amal\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Dawson, Jennifer\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Paliwoda, Michelle\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Walker, Karen\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"New, Karen\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Sultan Qaboos Univ Med J", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"COVID-19\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Infant, Newborn\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Oman\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"COVID-19/epidemiology\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Pandemics\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Mothers\"", "https://pesquisa.bvsalud.org/portal/resource/en/mdl-37658175", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Epstein, Rebecca\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Liberman, Leonardo\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Silver, Eric S\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Pediatr Cardiol", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Atrioventricular Block\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Child\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiac Conduction System Disease\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Heart\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Bundle-Branch Block/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Bundle-Branch Block/therapy\"", "https://pesquisa.bvsalud.org/portal/resource/en/mdl-37658392", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Peltoniemi, Suvi Oili Orvokki\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Glerup, Mia\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Lahdenne, Pekka\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Eklund, Kari K\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Aalto, Kristiina\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Pediatr Rheumatol Online J", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Arthritis, Juvenile\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"HLA-B27 Antigen\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cohort Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Finland/epidemiology\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"HLA-B27 Antigen/genetics\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Arthritis, Juvenile/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Arthritis, Juvenile/epidemiology\"", "https://pesquisa.bvsalud.org/portal/resource/en/mdl-37660023", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Wang, Yu\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Sun, Xu\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Li, Wenhan\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Shi, Benlong\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Liu, Zhen\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Wang, Bin\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Qiu, Yong\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Zhu, Zezhang\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=J Orthop Surg Res", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Kyphosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Scoliosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Scoliosis/diagnostic imaging\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Scoliosis/surgery\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Motion\"", "https://pesquisa.bvsalud.org/portal/resource/en/mdl-37661265", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Bakwa Kanyinga, Felly\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Gogovor, Am\u00e9d\u00e9\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Dofara, Su\u00e9l\u00e8ne Georgina\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Gadio, Souleymane\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Tremblay, Martin\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Daniel, Sam J\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Rivest, Louis-Paul\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"L\u00e9gar\u00e9, France\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=BMC Med Educ", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Physicians\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Health Personnel\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Health Behavior\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Data Accuracy\"", "https://pesquisa.bvsalud.org/portal/resource/en/mdl-37665847", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Laureys, Felien\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Collins, Dave\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Deconinck, Frederik J A\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Vansteenkiste, Pieter\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Lenoir, Matthieu\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Psychol Sport Exerc", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Athletes\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Gymnastics\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adolescent\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Child\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Young Adult\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cognition\"", "https://pesquisa.bvsalud.org/portal/resource/en/mdl-37663529", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Lu, Chiahao\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Khosla, Dhira\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Kent, Alexander\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Bronte-Stewart, Helen M\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Rosenbluth, Kathryn H\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Tremor Other Hyperkinet Mov (N Y)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Essential Tremor\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Essential Tremor/therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Tremor\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Retrospective Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Accelerometry\"", "https://pesquisa.bvsalud.org/portal/resource/en/mdl-37672406", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Antunes, Murillo Oliveira\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Arteaga-Fernandez, Edmundo\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Samesima, Nelson\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Pereira Filho, Hor\u00e1cio Gomes\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Matsumoto, Afonso Yoshikiro\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Verrier, Richard L\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Pastore, Carlos Alberto\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Mady, Charles\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Arq Bras Cardiol", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiomyopathy, Hypertrophic\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Tachycardia, Ventricular\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Prognosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Arrhythmias, Cardiac\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiomyopathy, Hypertrophic/complications\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiomyopathy, Hypertrophic/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Death, Sudden, Cardiac/etiology\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Tachycardia, Ventricular/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Ventricular Fibrillation/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Anti-Arrhythmia Agents\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cardiotonic Agents\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Diuretics\"", "https://pesquisa.bvsalud.org/portal/resource/en/mdl-37696637", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"L\u00f8kken, Bente Irene\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Sund, Erik R\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Krokstad, Steinar\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Bjerkeset, Ottar\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Rangul, Vegar\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=BMJ Open", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"General Practitioners\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Prospective Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Norway\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Referral and Consultation\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-218525", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Griep, Yannick\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Hanson, Linda Magnusson\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Leineweber, Constanze\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Geurts, Sabine A. E.\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Int. j. clin. health psychol. (Internet)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Stress, Psychological\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Depression\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Mental Health\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Volunteers\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Antidepressive Agents\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-ADZ-379", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Herranz-Pinto, P\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Figueras Nart, I\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Monte-Boquet, E\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Tortajada Goitia, B\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Actas dermo-sifiliogr. (Ed. impr.)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Pharmacy Service, Hospital\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Dermatitis, Atopic/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Delphi Technique\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Consensus\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-ADZ-380", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Herranz-Pinto, P\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Figueras Nart, I\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Monte-Boquet, E\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Tortajada Goitia, B\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Actas dermo-sifiliogr. (Ed. impr.)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Pharmacy Service, Hospital\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Dermatitis, Atopic/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Delphi Technique\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Consensus\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-223438", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Galeano-Valle, F\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Oblitas, C. M\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Gonz\u00e1lez-San-Narciso, C\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Esteban-San-Narciso, B. E\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Lafuente-G\u00f3mez, G\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Demelo-Rodr\u00edguez, P\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Rev. cl\u00edn. esp. (Ed. impr.)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adolescent\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Young Adult\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Adult\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Intracranial Thrombosis/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Venous Thrombosis/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Retrospective Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Recurrence\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Venous Thrombosis/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Venous Thrombosis/etiology\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Intracranial Thrombosis/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Intracranial Thrombosis/etiology\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Risk Factors\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Prognosis\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-224133", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Garc\u00eda-Campelo, Rosario\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Sullivan, Ivana\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Arriola, Edurne\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Insa, Amelia\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Vidal, Oscar Juan\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Cruz-Castellanos, Patricia\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Mor\u00e1n, Teresa\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Reguart, Noem\u00ed\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Zugazagoitia, Jon\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"D\u00f3mine, Manuel\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Clin. transl. oncol. (Print)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Antineoplastic Combined Chemotherapy Protocols/administration %26 dosage\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Etoposide/therapeutic use\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lung Neoplasms/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lung Neoplasms/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Platinum/therapeutic use\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Non-Small-Cell Lung/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Non-Small-Cell Lung/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Societies, Medical\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spain\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-224140", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Garc\u00eda-Campelo, Rosario\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Sullivan, Ivana\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Arriola, Edurne\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Insa, Amelia\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Vidal, Oscar Juan\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Cruz-Castellanos, Patricia\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Mor\u00e1n, Teresa\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Reguart, Noem\u00ed\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Zugazagoitia, Jon\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"D\u00f3mine, Manuel\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Clin. transl. oncol. (Print)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Antineoplastic Combined Chemotherapy Protocols/administration %26 dosage\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Etoposide/therapeutic use\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lung Neoplasms/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lung Neoplasms/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Platinum/therapeutic use\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Non-Small-Cell Lung/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Non-Small-Cell Lung/drug therapy\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Societies, Medical\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spain\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-224800", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Mu\u00ed\u00f1o-Dom\u00ednguez, D\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"G\u00f3mez-S\u00e1nchez, L\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Gallego-Fern\u00e1ndez, V\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Seoane-Pillado, T\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"L\u00f3pez-\u00c1lvarez, X. L\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.)", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Primary Prevention\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Hypertension/prevention %26 control\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Risk Factors\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Spain\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-224813", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Papa-Vettorazzi, R\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Pascual, L\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Moura-Coelho, N\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Freixes, S\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Arrondo, E\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Arch. Soc. Esp. Oftalmol", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Male\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Middle Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged, 80 and over\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Cataract Extraction\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Glaucoma/surgery\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Lasers, Excimer\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Ocular Hypertension/surgery\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Phacoemulsification\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Severity of Illness Index\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Treatment Outcome\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "https://pesquisa.bvsalud.org/portal/resource/en/ibc-224816", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Mozo Cuadrado, M\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Oliveira, A. de\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=au:\"Procianoy, F\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Arch. Soc. Esp. Oftalmol", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Humans\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Female\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Aged\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Basal Cell/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Carcinoma, Basal Cell/surgery\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Eyelid Neoplasms/diagnosis\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Eyelid Neoplasms/surgery\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Treatment Outcome\"", "https://pesquisa.bvsalud.org/portal/?lang=en&q=mh:\"Follow-Up Studies\"", "", "", "", "#", "#", "javascript:list_bookmark();", "javascript:clean_bookmark('');", "#", "#", "#", "#", "javascript:go_to_page('2')", "javascript:go_to_page('3')", "javascript:go_to_page('4')", "javascript:go_to_page('5')", "javascript:go_to_page('6')", "javascript:go_to_page('2')", "javascript:go_to_page('36308')", "https://bvsalud.org/en/contact_us/", "http://politicas.bireme.org/terminos/en/", "http://politicas.bireme.org/privacidad/en/", "javascript:export_result('20');", "javascript:export_result('selection');", "javascript:export_result();", "javascript:change_output('rss');", "javascript:;", "javascript:print_page();", "javascript:print_page(true);"]}